Maurits M. Vissers
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled Trials.
Journal: Clinical and translational science
Published: February 09, 2026
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.
Journal: Nature communications
Published: March 31, 2025
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial.
Journal: Nature medicine
Published: February 16, 2024
A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls.
Journal: Clinical and translational science
Published: December 13, 2022
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 07, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Journal: British journal of clinical pharmacology
Published: April 04, 2022
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.
Journal: Clinical and translational science
Published: March 04, 2022
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential Mechanism.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: November 29, 2021
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders.
Journal: International journal of molecular sciences
Published: December 24, 2020
The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.
Journal: British journal of clinical pharmacology
Published: June 08, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026